Curing epilepsy with precision gene therapy

We are advancing precision genetic therapies to target the abnormal brain circuits in epilepsy. Leveraging our discovery platform to target any brain cell type, Epicure has developed multiple assets with strong proof-of-concept data. We will be advancing these therapies to the clinic to help patients and families.